Buoyed By Strong Results, Bayer Stresses Asia Pacific As Driver Of Growth
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Bayer Healthcare Pharmaceuticals re-emphasized its sharp focus on the Asia-Pacific market terming it as an area of signficant investment opportunity and a "driver of growth" for the entire company